Drug Profile
Lamivudine/zidovudine + nevirapine - Hetero Drugs
Alternative Names: Zidovudine/lamivudine tablets + nevirapine tablets - Hetero DrugsLatest Information Update: 03 Dec 2018
Price :
$50
*
At a glance
- Originator Hetero Drugs
- Class 3-ring heterocyclic compounds; Antiretrovirals; Azepines; Azides; Cyclopropanes; Deoxyribonucleosides; Dideoxynucleosides; Nucleosides; Pyridines; Pyrimidine nucleosides; Small molecules
- Mechanism of Action Non-nucleoside reverse transcriptase inhibitors; Nucleoside reverse transcriptase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered HIV-1 infections
Most Recent Events
- 03 Dec 2018 Chemical structure information added
- 23 Nov 2018 Drug lamivudine/zidovudine co-packaged with nevirapine is not yet avaliable in USA for HIV-1 infections (Hetero Drugs website, November 2018)